Page last updated: 2024-11-13

monanchocidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

monanchocidin: from the marine sponge Monanchora; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID49794528
CHEMBL ID1822161
CHEBI ID69398
MeSH IDM0552718

Synonyms (7)

Synonym
CHEMBL1822161
chebi:69398 ,
monanchocidin a
monanchocidin
monanchocidin a, rel-
Q27137737
agjookrgjxjxte-saafptposa-n

Research Excerpts

Overview

Monanchocidin A is a novel alkaloid recently isolated from the marine sponge Monanchora pulchra. It contains an unusual highly oxidized morpholinone fragment.

ExcerptReferenceRelevance
"Monanchocidin A is a recently isolated pentacyclic guanidinium alkaloid that contains an unusual highly oxidized morpholinone fragment. "( Synthesis of the 5,6-dihydroxymorpholin-3-one fragment of monanchocidin A.
Pierce, JG; Shi, Y, 2015
)
2.1
"Monanchocidin A (MonA) is a novel alkaloid recently isolated from the marine sponge Monanchora pulchra. "( Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization.
Amann, K; Balabanov, S; Bokemeyer, C; Dyshlovoy, SA; Fedorov, SN; Guzii, AG; Hauschild, J; Honecker, F; Makarieva, TN; Shubina, LK; Stonik, VA; Tabakmakher, KM; Venz, S; von Amsberg, G; Walther, R, 2015
)
2.21
"Monanchocidin A (MonA) is a novel marine alkaloid with promising anti-cancer properties. "( Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmation.
Balabanov, S; Bokemeyer, C; Dyshlovoy, SA; Fedorov, SN; Guzii, AG; Hauschild, J; Honecker, F; Madanchi, R; Makarieva, TN; Otte, K; Shubina, LK; Stonik, VA; Tabakmakher, KM; V Amsberg, G; Venz, S; Walther, R, 2016
)
2.14
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholine receptor subunit alpha precursorMus musculus (house mouse)IC50 (µMol)4.10004.10004.10004.1000AID743368
Acetylcholine receptor subunit alphaTetronarce californica (Pacific electric ray)Ki8.00000.00279.359634.0000AID743370
Acetylcholine receptor subunit betaTetronarce californica (Pacific electric ray)Ki8.00000.002711.753834.0000AID743370
Acetylcholine receptor subunit gammaTetronarce californica (Pacific electric ray)Ki8.00000.002711.753834.0000AID743370
Acetylcholine receptor subunit deltaTetronarce californica (Pacific electric ray)Ki8.00000.000110.074734.0000AID743370
Acetylcholine-binding proteinLymnaea stagnalis (great pond snail)Ki2.50000.00011.881128.0000AID743369
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID743370In vitro ability to inhibit the binding of [125I]alpha-bungarotoxin to Nicotinic acetylcholine receptor on membranes prepared from the electric organs of Torpedo californica2014Marine drugs, Mar-28, Volume: 12, Issue:4
Marine natural products acting on the acetylcholine-binding protein and nicotinic receptors: from computer modeling to binding studies and electrophysiology.
AID743368Inhibition of functional activity of Mus musculus muscle nicotinic acetylcholine receptor expressed in Xenopus oocytes2014Marine drugs, Mar-28, Volume: 12, Issue:4
Marine natural products acting on the acetylcholine-binding protein and nicotinic receptors: from computer modeling to binding studies and electrophysiology.
AID743369Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP2014Marine drugs, Mar-28, Volume: 12, Issue:4
Marine natural products acting on the acetylcholine-binding protein and nicotinic receptors: from computer modeling to binding studies and electrophysiology.
AID1478818Inhibition of eIF5A-1 (unknown origin) at 1 uM2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Structure, synthesis and biological properties of the pentacyclic guanidinium alkaloids.
AID616387Cytotoxicity against human HL60 cells after 72 hrs by MTS assay2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Monanchocidins B-E: polycyclic guanidine alkaloids with potent antileukemic activities from the sponge Monanchora pulchra.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]